Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?

SIMPLE SUMMARY: Advanced epithelial ovarian cancer has a poor prognosis, but targeted therapies have been developed and are providing new hope. We reviewed recent results with PARP inhibitors as treatment and/or maintenance therapy following chemotherapy in newly diagnosed advanced ovarian cancer. D...

Descripción completa

Detalles Bibliográficos
Autores principales: DiSilvestro, Paul, Colombo, Nicoletta, Harter, Philipp, González-Martín, Antonio, Ray-Coquard, Isabelle, Coleman, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616471/
https://www.ncbi.nlm.nih.gov/pubmed/34830911
http://dx.doi.org/10.3390/cancers13225756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616471/
https://www.ncbi.nlm.nih.gov/pubmed/34830911
http://dx.doi.org/10.3390/cancers13225756

Ejemplares similares